Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-13-005059
Filing Date
2013-05-01
Accepted
2013-05-01 15:32:18
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gvox_10q-033113.htm 10-Q 371940
2 EXHIBIT 31.1 ex31-1.htm EX-31.1 14850
3 EXHIBIT 31.2 ex31-2.htm EX-31.2 14663
4 EXHIBIT 32.1 ex32-1.htm EX-32.1 5561
5 EXHIBIT 32.2 ex32-2.htm EX-32.2 5247
  Complete submission text file 0001437749-13-005059.txt   1939235

Data Files

Seq Description Document Type Size
6 govx-20130331.xml EX-101.INS 169532
7 govx-20130331.xsd EX-101.SCH 24861
8 govx-20130331_cal.xml EX-101.CAL 19976
9 govx-20130331_def.xml EX-101.DEF 120112
10 govx-20130331_lab.xml EX-101.LAB 173307
11 govx-20130331_pre.xml EX-101.PRE 123641
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA 2Q 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52091 | Film No.: 13802833
SIC: 8731 Services-Commercial Physical & Biological Research